Toolkit/light-oxygen-voltage (LOV) sensor domain

light-oxygen-voltage (LOV) sensor domain

Protein Domain·Research·Since 2014

Also known as: LOV sensor domain

Taxonomy: Mechanism Branch / Component. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

The light-oxygen-voltage (LOV) sensor domain is a light-responsive regulatory protein domain characterized in the monomeric histidine kinase EL346. Structural evidence indicates that it binds one side of the DHpL domain to control kinase output, prevent dimerization, and release the catalytic apparatus from an inhibited conformation upon photoactivation.

Usefulness & Problems

Why this is useful

This domain is useful as a genetically encoded light input module for regulating histidine kinase signaling through intramolecular control of catalytic state. The available evidence specifically supports its ability to couple light sensing to changes in DHpL/CA domain organization and kinase regulation in EL346.

Problem solved

It addresses the problem of how a photosensory domain can regulate a monomeric histidine kinase without relying on constitutive dimerization. In EL346, the LOV domain provides a structural mechanism for maintaining dark-state inhibition and relieving that inhibition after light activation.

Problem links

Need conditional control of signaling activity

Derived

The light-oxygen-voltage (LOV) sensor domain is a light-responsive protein domain characterized here in the monomeric histidine kinase EL346. Structural evidence indicates that it regulates kinase output by binding one side of the DHpL domain, preventing dimerization and controlling the inhibited versus activated state of the catalytic apparatus.

Need precise spatiotemporal control with light input

Derived

The light-oxygen-voltage (LOV) sensor domain is a light-responsive protein domain characterized here in the monomeric histidine kinase EL346. Structural evidence indicates that it regulates kinase output by binding one side of the DHpL domain, preventing dimerization and controlling the inhibited versus activated state of the catalytic apparatus.

Taxonomy & Function

Primary hierarchy

Mechanism Branch

Component: A low-level protein part used inside a larger architecture that realizes a mechanism.

Techniques

No technique tags yet.

Target processes

signaling

Input: Light

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationimplementation constraint: multi component delivery burdenimplementation constraint: spectral hardware requirementoperating role: sensorswitch architecture: multi componentswitch architecture: recruitmentswitch architecture: uncaging

The supported implementation context is the full-length monomeric histidine kinase EL346, where the LOV domain acts through physical interaction with the DHpL domain and influences the DHpL/CA interface. The supplied evidence does not provide construct design rules, cofactor requirements, expression conditions, or delivery guidance.

The evidence appears to come from a single structural study in one protein context, EL346. Quantitative performance metrics, spectral parameters, transferability to other proteins, and independent replication are not provided in the supplied evidence.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1dark state inhibitionsupports2014Source 1needs review

The DHpL domain contacts the CA domain and keeps EL346 in an inhibited conformation in the dark.

The DHpL domain also contacts the catalytic/ATP-binding (CA) domain, keeping EL346 in an inhibited conformation in the dark.
Claim 2dark state inhibitionsupports2014Source 1needs review

The DHpL domain contacts the CA domain and keeps EL346 in an inhibited conformation in the dark.

The DHpL domain also contacts the catalytic/ATP-binding (CA) domain, keeping EL346 in an inhibited conformation in the dark.
Claim 3dark state inhibitionsupports2014Source 1needs review

The DHpL domain contacts the CA domain and keeps EL346 in an inhibited conformation in the dark.

The DHpL domain also contacts the catalytic/ATP-binding (CA) domain, keeping EL346 in an inhibited conformation in the dark.
Claim 4dark state inhibitionsupports2014Source 1needs review

The DHpL domain contacts the CA domain and keeps EL346 in an inhibited conformation in the dark.

The DHpL domain also contacts the catalytic/ATP-binding (CA) domain, keeping EL346 in an inhibited conformation in the dark.
Claim 5dark state inhibitionsupports2014Source 1needs review

The DHpL domain contacts the CA domain and keeps EL346 in an inhibited conformation in the dark.

The DHpL domain also contacts the catalytic/ATP-binding (CA) domain, keeping EL346 in an inhibited conformation in the dark.
Claim 6dark state inhibitionsupports2014Source 1needs review

The DHpL domain contacts the CA domain and keeps EL346 in an inhibited conformation in the dark.

The DHpL domain also contacts the catalytic/ATP-binding (CA) domain, keeping EL346 in an inhibited conformation in the dark.
Claim 7dark state inhibitionsupports2014Source 1needs review

The DHpL domain contacts the CA domain and keeps EL346 in an inhibited conformation in the dark.

The DHpL domain also contacts the catalytic/ATP-binding (CA) domain, keeping EL346 in an inhibited conformation in the dark.
Claim 8dark state inhibitionsupports2014Source 1needs review

The DHpL domain contacts the CA domain and keeps EL346 in an inhibited conformation in the dark.

The DHpL domain also contacts the catalytic/ATP-binding (CA) domain, keeping EL346 in an inhibited conformation in the dark.
Claim 9dark state inhibitionsupports2014Source 1needs review

The DHpL domain contacts the CA domain and keeps EL346 in an inhibited conformation in the dark.

The DHpL domain also contacts the catalytic/ATP-binding (CA) domain, keeping EL346 in an inhibited conformation in the dark.
Claim 10dark state inhibitionsupports2014Source 1needs review

The DHpL domain contacts the CA domain and keeps EL346 in an inhibited conformation in the dark.

The DHpL domain also contacts the catalytic/ATP-binding (CA) domain, keeping EL346 in an inhibited conformation in the dark.
Claim 11mechanism of regulationsupports2014Source 1needs review

The LOV sensor domain controls kinase activity and prevents dimerization by binding one side of the DHpL domain.

Its structure reveals that the light-oxygen-voltage (LOV) sensor domain both controls kinase activity and prevents dimerization by binding one side of a dimerization/histidine phosphotransfer-like (DHpL) domain.
Claim 12mechanism of regulationsupports2014Source 1needs review

The LOV sensor domain controls kinase activity and prevents dimerization by binding one side of the DHpL domain.

Its structure reveals that the light-oxygen-voltage (LOV) sensor domain both controls kinase activity and prevents dimerization by binding one side of a dimerization/histidine phosphotransfer-like (DHpL) domain.
Claim 13mechanism of regulationsupports2014Source 1needs review

The LOV sensor domain controls kinase activity and prevents dimerization by binding one side of the DHpL domain.

Its structure reveals that the light-oxygen-voltage (LOV) sensor domain both controls kinase activity and prevents dimerization by binding one side of a dimerization/histidine phosphotransfer-like (DHpL) domain.
Claim 14mechanism of regulationsupports2014Source 1needs review

The LOV sensor domain controls kinase activity and prevents dimerization by binding one side of the DHpL domain.

Its structure reveals that the light-oxygen-voltage (LOV) sensor domain both controls kinase activity and prevents dimerization by binding one side of a dimerization/histidine phosphotransfer-like (DHpL) domain.
Claim 15mechanism of regulationsupports2014Source 1needs review

The LOV sensor domain controls kinase activity and prevents dimerization by binding one side of the DHpL domain.

Its structure reveals that the light-oxygen-voltage (LOV) sensor domain both controls kinase activity and prevents dimerization by binding one side of a dimerization/histidine phosphotransfer-like (DHpL) domain.
Claim 16mechanism of regulationsupports2014Source 1needs review

The LOV sensor domain controls kinase activity and prevents dimerization by binding one side of the DHpL domain.

Its structure reveals that the light-oxygen-voltage (LOV) sensor domain both controls kinase activity and prevents dimerization by binding one side of a dimerization/histidine phosphotransfer-like (DHpL) domain.
Claim 17mechanism of regulationsupports2014Source 1needs review

The LOV sensor domain controls kinase activity and prevents dimerization by binding one side of the DHpL domain.

Its structure reveals that the light-oxygen-voltage (LOV) sensor domain both controls kinase activity and prevents dimerization by binding one side of a dimerization/histidine phosphotransfer-like (DHpL) domain.
Claim 18mechanism of regulationsupports2014Source 1needs review

The LOV sensor domain controls kinase activity and prevents dimerization by binding one side of the DHpL domain.

Its structure reveals that the light-oxygen-voltage (LOV) sensor domain both controls kinase activity and prevents dimerization by binding one side of a dimerization/histidine phosphotransfer-like (DHpL) domain.
Claim 19mechanism of regulationsupports2014Source 1needs review

The LOV sensor domain controls kinase activity and prevents dimerization by binding one side of the DHpL domain.

Its structure reveals that the light-oxygen-voltage (LOV) sensor domain both controls kinase activity and prevents dimerization by binding one side of a dimerization/histidine phosphotransfer-like (DHpL) domain.
Claim 20mechanism of regulationsupports2014Source 1needs review

The LOV sensor domain controls kinase activity and prevents dimerization by binding one side of the DHpL domain.

Its structure reveals that the light-oxygen-voltage (LOV) sensor domain both controls kinase activity and prevents dimerization by binding one side of a dimerization/histidine phosphotransfer-like (DHpL) domain.
Claim 21mechanism of regulationsupports2014Source 1needs review

The LOV sensor domain controls kinase activity and prevents dimerization by binding one side of the DHpL domain.

Its structure reveals that the light-oxygen-voltage (LOV) sensor domain both controls kinase activity and prevents dimerization by binding one side of a dimerization/histidine phosphotransfer-like (DHpL) domain.
Claim 22mechanism of regulationsupports2014Source 1needs review

The LOV sensor domain controls kinase activity and prevents dimerization by binding one side of the DHpL domain.

Its structure reveals that the light-oxygen-voltage (LOV) sensor domain both controls kinase activity and prevents dimerization by binding one side of a dimerization/histidine phosphotransfer-like (DHpL) domain.
Claim 23mechanism of regulationsupports2014Source 1needs review

The LOV sensor domain controls kinase activity and prevents dimerization by binding one side of the DHpL domain.

Its structure reveals that the light-oxygen-voltage (LOV) sensor domain both controls kinase activity and prevents dimerization by binding one side of a dimerization/histidine phosphotransfer-like (DHpL) domain.
Claim 24mechanism of regulationsupports2014Source 1needs review

The LOV sensor domain controls kinase activity and prevents dimerization by binding one side of the DHpL domain.

Its structure reveals that the light-oxygen-voltage (LOV) sensor domain both controls kinase activity and prevents dimerization by binding one side of a dimerization/histidine phosphotransfer-like (DHpL) domain.
Claim 25mechanism of regulationsupports2014Source 1needs review

The LOV sensor domain controls kinase activity and prevents dimerization by binding one side of the DHpL domain.

Its structure reveals that the light-oxygen-voltage (LOV) sensor domain both controls kinase activity and prevents dimerization by binding one side of a dimerization/histidine phosphotransfer-like (DHpL) domain.
Claim 26mechanism of regulationsupports2014Source 1needs review

The LOV sensor domain controls kinase activity and prevents dimerization by binding one side of the DHpL domain.

Its structure reveals that the light-oxygen-voltage (LOV) sensor domain both controls kinase activity and prevents dimerization by binding one side of a dimerization/histidine phosphotransfer-like (DHpL) domain.
Claim 27mechanism of regulationsupports2014Source 1needs review

The LOV sensor domain controls kinase activity and prevents dimerization by binding one side of the DHpL domain.

Its structure reveals that the light-oxygen-voltage (LOV) sensor domain both controls kinase activity and prevents dimerization by binding one side of a dimerization/histidine phosphotransfer-like (DHpL) domain.
Claim 28mechanistic modelsupports2014Source 1needs review

The LOV domain controls kinase activity by affecting stability of the DHpL/CA interface and releasing the CA domain from an inhibited conformation upon photoactivation.

Our data suggest that the LOV domain controls kinase activity by affecting the stability of the DHpL/CA interface, releasing the CA domain from an inhibited conformation upon photoactivation.
Claim 29mechanistic modelsupports2014Source 1needs review

The LOV domain controls kinase activity by affecting stability of the DHpL/CA interface and releasing the CA domain from an inhibited conformation upon photoactivation.

Our data suggest that the LOV domain controls kinase activity by affecting the stability of the DHpL/CA interface, releasing the CA domain from an inhibited conformation upon photoactivation.
Claim 30mechanistic modelsupports2014Source 1needs review

The LOV domain controls kinase activity by affecting stability of the DHpL/CA interface and releasing the CA domain from an inhibited conformation upon photoactivation.

Our data suggest that the LOV domain controls kinase activity by affecting the stability of the DHpL/CA interface, releasing the CA domain from an inhibited conformation upon photoactivation.
Claim 31mechanistic modelsupports2014Source 1needs review

The LOV domain controls kinase activity by affecting stability of the DHpL/CA interface and releasing the CA domain from an inhibited conformation upon photoactivation.

Our data suggest that the LOV domain controls kinase activity by affecting the stability of the DHpL/CA interface, releasing the CA domain from an inhibited conformation upon photoactivation.
Claim 32mechanistic modelsupports2014Source 1needs review

The LOV domain controls kinase activity by affecting stability of the DHpL/CA interface and releasing the CA domain from an inhibited conformation upon photoactivation.

Our data suggest that the LOV domain controls kinase activity by affecting the stability of the DHpL/CA interface, releasing the CA domain from an inhibited conformation upon photoactivation.
Claim 33mechanistic modelsupports2014Source 1needs review

The LOV domain controls kinase activity by affecting stability of the DHpL/CA interface and releasing the CA domain from an inhibited conformation upon photoactivation.

Our data suggest that the LOV domain controls kinase activity by affecting the stability of the DHpL/CA interface, releasing the CA domain from an inhibited conformation upon photoactivation.
Claim 34mechanistic modelsupports2014Source 1needs review

The LOV domain controls kinase activity by affecting stability of the DHpL/CA interface and releasing the CA domain from an inhibited conformation upon photoactivation.

Our data suggest that the LOV domain controls kinase activity by affecting the stability of the DHpL/CA interface, releasing the CA domain from an inhibited conformation upon photoactivation.
Claim 35mechanistic modelsupports2014Source 1needs review

The LOV domain controls kinase activity by affecting stability of the DHpL/CA interface and releasing the CA domain from an inhibited conformation upon photoactivation.

Our data suggest that the LOV domain controls kinase activity by affecting the stability of the DHpL/CA interface, releasing the CA domain from an inhibited conformation upon photoactivation.
Claim 36mechanistic modelsupports2014Source 1needs review

The LOV domain controls kinase activity by affecting stability of the DHpL/CA interface and releasing the CA domain from an inhibited conformation upon photoactivation.

Our data suggest that the LOV domain controls kinase activity by affecting the stability of the DHpL/CA interface, releasing the CA domain from an inhibited conformation upon photoactivation.
Claim 37mechanistic modelsupports2014Source 1needs review

The LOV domain controls kinase activity by affecting stability of the DHpL/CA interface and releasing the CA domain from an inhibited conformation upon photoactivation.

Our data suggest that the LOV domain controls kinase activity by affecting the stability of the DHpL/CA interface, releasing the CA domain from an inhibited conformation upon photoactivation.
Claim 38mechanistic modelsupports2014Source 1needs review

The LOV domain controls kinase activity by affecting stability of the DHpL/CA interface and releasing the CA domain from an inhibited conformation upon photoactivation.

Our data suggest that the LOV domain controls kinase activity by affecting the stability of the DHpL/CA interface, releasing the CA domain from an inhibited conformation upon photoactivation.
Claim 39mechanistic modelsupports2014Source 1needs review

The LOV domain controls kinase activity by affecting stability of the DHpL/CA interface and releasing the CA domain from an inhibited conformation upon photoactivation.

Our data suggest that the LOV domain controls kinase activity by affecting the stability of the DHpL/CA interface, releasing the CA domain from an inhibited conformation upon photoactivation.
Claim 40mechanistic modelsupports2014Source 1needs review

The LOV domain controls kinase activity by affecting stability of the DHpL/CA interface and releasing the CA domain from an inhibited conformation upon photoactivation.

Our data suggest that the LOV domain controls kinase activity by affecting the stability of the DHpL/CA interface, releasing the CA domain from an inhibited conformation upon photoactivation.
Claim 41mechanistic modelsupports2014Source 1needs review

The LOV domain controls kinase activity by affecting stability of the DHpL/CA interface and releasing the CA domain from an inhibited conformation upon photoactivation.

Our data suggest that the LOV domain controls kinase activity by affecting the stability of the DHpL/CA interface, releasing the CA domain from an inhibited conformation upon photoactivation.
Claim 42mechanistic modelsupports2014Source 1needs review

The LOV domain controls kinase activity by affecting stability of the DHpL/CA interface and releasing the CA domain from an inhibited conformation upon photoactivation.

Our data suggest that the LOV domain controls kinase activity by affecting the stability of the DHpL/CA interface, releasing the CA domain from an inhibited conformation upon photoactivation.
Claim 43mechanistic modelsupports2014Source 1needs review

The LOV domain controls kinase activity by affecting stability of the DHpL/CA interface and releasing the CA domain from an inhibited conformation upon photoactivation.

Our data suggest that the LOV domain controls kinase activity by affecting the stability of the DHpL/CA interface, releasing the CA domain from an inhibited conformation upon photoactivation.
Claim 44mechanistic modelsupports2014Source 1needs review

The LOV domain controls kinase activity by affecting stability of the DHpL/CA interface and releasing the CA domain from an inhibited conformation upon photoactivation.

Our data suggest that the LOV domain controls kinase activity by affecting the stability of the DHpL/CA interface, releasing the CA domain from an inhibited conformation upon photoactivation.
Claim 45photoactivation mechanismsupports2014Source 1needs review

Light stimulation weakens interdomain interactions to facilitate EL346 activation.

Upon light stimulation, interdomain interactions weaken to facilitate activation.
Claim 46photoactivation mechanismsupports2014Source 1needs review

Light stimulation weakens interdomain interactions to facilitate EL346 activation.

Upon light stimulation, interdomain interactions weaken to facilitate activation.
Claim 47photoactivation mechanismsupports2014Source 1needs review

Light stimulation weakens interdomain interactions to facilitate EL346 activation.

Upon light stimulation, interdomain interactions weaken to facilitate activation.
Claim 48photoactivation mechanismsupports2014Source 1needs review

Light stimulation weakens interdomain interactions to facilitate EL346 activation.

Upon light stimulation, interdomain interactions weaken to facilitate activation.
Claim 49photoactivation mechanismsupports2014Source 1needs review

Light stimulation weakens interdomain interactions to facilitate EL346 activation.

Upon light stimulation, interdomain interactions weaken to facilitate activation.
Claim 50photoactivation mechanismsupports2014Source 1needs review

Light stimulation weakens interdomain interactions to facilitate EL346 activation.

Upon light stimulation, interdomain interactions weaken to facilitate activation.
Claim 51photoactivation mechanismsupports2014Source 1needs review

Light stimulation weakens interdomain interactions to facilitate EL346 activation.

Upon light stimulation, interdomain interactions weaken to facilitate activation.
Claim 52photoactivation mechanismsupports2014Source 1needs review

Light stimulation weakens interdomain interactions to facilitate EL346 activation.

Upon light stimulation, interdomain interactions weaken to facilitate activation.
Claim 53photoactivation mechanismsupports2014Source 1needs review

Light stimulation weakens interdomain interactions to facilitate EL346 activation.

Upon light stimulation, interdomain interactions weaken to facilitate activation.
Claim 54photoactivation mechanismsupports2014Source 1needs review

Light stimulation weakens interdomain interactions to facilitate EL346 activation.

Upon light stimulation, interdomain interactions weaken to facilitate activation.
Claim 55structural statesupports2014Source 1needs review

EL346 functions as a monomer rather than as a dimeric histidine kinase.

Contrary to the standard view that signaling occurs within HK dimers, EL346 functions as a monomer.
Claim 56structural statesupports2014Source 1needs review

EL346 functions as a monomer rather than as a dimeric histidine kinase.

Contrary to the standard view that signaling occurs within HK dimers, EL346 functions as a monomer.
Claim 57structural statesupports2014Source 1needs review

EL346 functions as a monomer rather than as a dimeric histidine kinase.

Contrary to the standard view that signaling occurs within HK dimers, EL346 functions as a monomer.
Claim 58structural statesupports2014Source 1needs review

EL346 functions as a monomer rather than as a dimeric histidine kinase.

Contrary to the standard view that signaling occurs within HK dimers, EL346 functions as a monomer.
Claim 59structural statesupports2014Source 1needs review

EL346 functions as a monomer rather than as a dimeric histidine kinase.

Contrary to the standard view that signaling occurs within HK dimers, EL346 functions as a monomer.
Claim 60structural statesupports2014Source 1needs review

EL346 functions as a monomer rather than as a dimeric histidine kinase.

Contrary to the standard view that signaling occurs within HK dimers, EL346 functions as a monomer.
Claim 61structural statesupports2014Source 1needs review

EL346 functions as a monomer rather than as a dimeric histidine kinase.

Contrary to the standard view that signaling occurs within HK dimers, EL346 functions as a monomer.
Claim 62structural statesupports2014Source 1needs review

EL346 functions as a monomer rather than as a dimeric histidine kinase.

Contrary to the standard view that signaling occurs within HK dimers, EL346 functions as a monomer.
Claim 63structural statesupports2014Source 1needs review

EL346 functions as a monomer rather than as a dimeric histidine kinase.

Contrary to the standard view that signaling occurs within HK dimers, EL346 functions as a monomer.
Claim 64structural statesupports2014Source 1needs review

EL346 functions as a monomer rather than as a dimeric histidine kinase.

Contrary to the standard view that signaling occurs within HK dimers, EL346 functions as a monomer.

Approval Evidence

1 source2 linked approval claimsfirst-pass slug light-oxygen-voltage-lov-sensor-domain
Its structure reveals that the light-oxygen-voltage (LOV) sensor domain both controls kinase activity and prevents dimerization

Source:

mechanism of regulationsupports

The LOV sensor domain controls kinase activity and prevents dimerization by binding one side of the DHpL domain.

Its structure reveals that the light-oxygen-voltage (LOV) sensor domain both controls kinase activity and prevents dimerization by binding one side of a dimerization/histidine phosphotransfer-like (DHpL) domain.

Source:

mechanistic modelsupports

The LOV domain controls kinase activity by affecting stability of the DHpL/CA interface and releasing the CA domain from an inhibited conformation upon photoactivation.

Our data suggest that the LOV domain controls kinase activity by affecting the stability of the DHpL/CA interface, releasing the CA domain from an inhibited conformation upon photoactivation.

Source:

Comparisons

Source-backed strengths

Structural analysis of full-length EL346 provides a concrete mechanistic model linking the LOV domain to kinase regulation. The evidence supports multiple connected functions: prevention of dimerization, stabilization of an inhibited dark-state arrangement, and photoactivation-associated release of the CA domain from inhibition.

Compared with EL346

light-oxygen-voltage (LOV) sensor domain and EL346 address a similar problem space because they share signaling.

Shared frame: same top-level item type; shared target processes: signaling; shared mechanisms: heterodimerization, light-dependent allosteric switching; same primary input modality: light

light-oxygen-voltage (LOV) sensor domain and light-oxygen-voltage sensing (LOV) domain address a similar problem space because they share signaling.

Shared frame: same top-level item type; shared target processes: signaling; shared mechanisms: heterodimerization; same primary input modality: light

Compared with optogenetic RGS2

light-oxygen-voltage (LOV) sensor domain and optogenetic RGS2 address a similar problem space because they share signaling.

Shared frame: same top-level item type; shared target processes: signaling; shared mechanisms: heterodimerization; same primary input modality: light

Ranked Citations

  1. 1.
    StructuralSource 1Proceedings of the National Academy of Sciences2014Claim 7Claim 7Claim 7

    Extracted from this source document.